Cibus Global LLC

NASDAQ:CBUS USA Biotechnology
Market Cap
$243.03 Million
Market Cap Rank
#16806 Global
#6437 in USA
Share Price
$3.68
Change (1 day)
+3.37%
52-Week Range
$1.16 - $4.05
All Time High
$1574.00
About

Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable i… Read more

Cibus Global LLC - Asset Resilience Ratio

Latest as of March 2021: 5.81%

Cibus Global LLC (CBUS) has an Asset Resilience Ratio of 5.81% as of March 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$3.04 Million
Cash + Short-term Investments
Total Assets
$52.43 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2021)

This chart shows how Cibus Global LLC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Cibus Global LLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $3.04 Million 5.81%
Total Liquid Assets $3.04 Million 5.81%

Asset Resilience Insights

  • Limited Liquidity: Cibus Global LLC maintains only 5.81% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Cibus Global LLC Industry Peers by Asset Resilience Ratio

Compare Cibus Global LLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Cibus Global LLC (2016–2021)

The table below shows the annual Asset Resilience Ratio data for Cibus Global LLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 0.00% $0.00 $37.19 Million --
2020-12-31 18.47% $11.70 Million $63.33 Million --
2019-12-31 0.00% $0.00 $88.10 Million --
2017-12-31 0.56% $402.00K $72.17 Million -2.66pp
2016-12-31 3.22% $535.00K $16.62 Million --
pp = percentage points